Nanoparticles of Block Ionomer Complexes from Double Hydrophilic Poly(acrylic acid)-b-poly(ethylene oxide)-b-poly(acrylic acid) Triblock Copolymer and Oppositely Charged Surfactant

The novel water-dispersible nanoparticles from the double hydrophilic poly(acrylic acid)-b-poly(ethylene oxide)-b-poly(acrylic acid) (PAA-b-PEO-b-PAA) triblock copolymer and oppositely charged surfactant dodecyltrimethyl ammonium bromide (DTAB) were prepared by mixing the individual aqueous solutions. The structure of the nanoparticles was investigated as a function of the degree of neutralization (DN) by turbidimetry, dynamic light scattering (DSL),ζ-potential measurement, and atomic force microscope (AFM). The neutralization of the anionic PAA blocks with cationic DTAB accompanied with the hydrophobic interaction of alkyl tails of DTAB led to formation of core–shell nanoparticles with the core of the DTAB neutralized PAA blocks and the shell of the looped PEO blocks. The water-dispersible nanoparticles with negative ζ-potential were obtained over the DN range from 0.4 to 2.0 and their sizes depended on the DN. The looped PEO blocks hindered the further neutralization of the PAA blocks with cationic DTAB, resulting in existence of some negative charged PAA-b-PEO-b-PAA backbones even when DN > 1.0. The spherical and ellipsoidal nature of these nanoparticles was observed with AFM

Light regulation of metabolic pathways in fungi

Light represents a major carrier of information in nature. The molecular machineries translating its electromagnetic energy (photons) into the chemical language of cells transmit vital signals for adjustment of virtually every living organism to its habitat. Fungi react to illumination in various ways, and we found that they initiate considerable adaptations in their metabolic pathways upon growth in light or after perception of a light pulse. Alterations in response to light have predominantly been observed in carotenoid metabolism, polysaccharide and carbohydrate metabolism, fatty acid metabolism, nucleotide and nucleoside metabolism, and in regulation of production of secondary metabolites. Transcription of genes is initiated within minutes, abundance and activity of metabolic enzymes are adjusted, and subsequently, levels of metabolites are altered to cope with the harmful effects of light or to prepare for reproduction, which is dependent on light in many cases. This review aims to give an overview on metabolic pathways impacted by light and to illustrate the physiological significance of light for fungi. We provide a basis for assessment whether a given metabolic pathway might be subject to regulation by light and how these properties can be exploited for improvement of biotechnological processes

Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms.

The vast majority of gastrin-related gastrointestinal neuroendocrine neoplasms (GI-NENs) develop in the context of chronic atrophic gastritis (type 1), a condition closely related to autoimmune thyroid diseases. These neoplasms are defined as gastric NENs type 1 (GNEN1) and have recently been shown to constitute the commonest GI-NENs in a prospective study. GNEN1s are usually multiple and follow a relative indolent course, raising questions regarding the extent that such patients should be investigated and the appropriate therapeutic interventions needed. Recently, a number of consensus statements and guidelines have been published from various societies dealing with the diagnosis and management of GI-NENs. Endocrinologists are among the many different medical specialties involved in GNEN1s diagnosis and management. However, despite recent advances, few randomized trials are available, and thus existing evidence remains relatively weak compared to other malignancies. The purpose of this review is to provide recent evidence along with currently employed modalities addressing the diagnosis, management, long-term follow-up and potential comorbidities of GNEN1s

Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms.

The vast majority of gastrin-related gastrointestinal neuroendocrine neoplasms (GI-NENs) develop in the context of chronic atrophic gastritis (type 1), a condition closely related to autoimmune thyroid diseases. These neoplasms are defined as gastric NENs type 1 (GNEN1) and have recently been shown to constitute the commonest GI-NENs in a prospective study. GNEN1s are usually multiple and follow a relative indolent course, raising questions regarding the extent that such patients should be investigated and the appropriate therapeutic interventions needed. Recently, a number of consensus statements and guidelines have been published from various societies dealing with the diagnosis and management of GI-NENs. Endocrinologists are among the many different medical specialties involved in GNEN1s diagnosis and management. However, despite recent advances, few randomized trials are available, and thus existing evidence remains relatively weak compared to other malignancies. The purpose of this review is to provide recent evidence along with currently employed modalities addressing the diagnosis, management, long-term follow-up and potential comorbidities of GNEN1s